Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Millipore

This article was originally published in The Gray Sheet

Executive Summary

Plans to use approximately $300 mil. of an estimated $360 mil. in proceeds from the sale of its Waters Chromatography division for the repurchase of stock. The remaining funds would go towards taxes, fees and expenses, the Bedford, Massachusetts firm explains. The repurchase program is not expected to begin before completion of the divestiture, which is anticipated at the end of the second quarter
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002234

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel